Presented By: John Owen | Group CEO Abhishek Singh | Group CFO Table of Contents
Total Page:16
File Type:pdf, Size:1020Kb
Presented by: John Owen | Group CEO Abhishek Singh | Group CFO Table of Contents 01. Highlights of the Quarter 02. Financial Performance 03. Operational Performance 04. Key Wins for the Quarter 05. Evosys Advantage 06. Acquisition and Covid Updates Mastek Limited | Investor Presentation 2021 | Presentation title in footer 2 Highlights 01 of the Quarter 02 03 04 05 06 Highlights of the Quarter Mastek crossed $55m revenue Improvement in Operating Mastek and Evosys mark in the Q2 EBITDA margin of 350 bps signed second deal in QoQ H1FY21 under “Joint Go- Q1 Q2 Q3 Q4 21.1% Operating To Market strategy” Q2 FY EBITDA margin 21 6.1% QoQ revenue growth in Q2FY21 Mastek Joint Go-To Market Evosys strategy Added 37 new customers Increase in 12Month order during the quarter backlog to Rs 940 cores 37 new 23.0% QoQ Order value customers growth of $7.7 million Declared interim dividend of 110% or Rs 5.5 per share Mastek Limited | Investor Presentation 2021 | 4 Financial 02 Performance 01 02 03 04 05 06 Consistent 68.2% Financial Performance Revenue growth YoY Revenue from Operations Operating EBITDA Margin PAT Margin 21.1% 21.1% Operating 17.6% 17.3% EBITDA margin 13.8% improved by 936 bps 12.7% 12.8% 13.2% 13.3% 12.1% 12.0% 12.3% 12.4% 12.2% 11.8% 14.3% YoY 11.0% 11.6% 10.3% 9.4% 9.8% 10.0% 9.6% 9.7% 8.6% 8.6% 9.1% 7.8% 8.4% 14.3% PAT Margin 186 198 210 224 244 257 265 267 248 244 244 337 386 410 improved by 454 bps Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 Q3FY19 Q4FY19 Q1FY20 Q2FY20 Q3FY20 Q4FY20 Q1FY21 Q2FY21 YoY Mastek Limited | Investor Presentation 2021 | 6 Financial Summary – Q2 FY21 Growth Growth Key Performance Metrics Q2FY21 Q1FY21 Q2FY20 QoQ YoY Revenue from Operations* ($m) $55.1 $50.8 $34.4 5.3% (CC) 56.3% (CC) Revenue from Operations* (Rs Crore) 409.7 386.1 243.6 6.1% 68.2% Revenue Other Income (Rs Crore) 4.1 16.7 9.1 (75.7%) (55.5%) Total Income (Rs Crore) 413.8 402.8 252.7 2.7% 63.7% Op. EBITDA 86.6 68.1 28.7 27.1% 202.1% Margins Total EBITDA 90.6 84.8 37.8 6.8% 139.9% (Rs Crore) PBT 76.9 70.9 31.3 8.4% 145.8% PAT 59.1 46.6 24.6 27.0% 140.0% Op. EBITDA 21.1% 17.6% 11.8% 348 bps 936 bps Margin (%) Total EBITDA 21.9% 21.1% 14.9% 84 bps 695 bps PBT 18.6% 17.6% 12.4% 97 bps 620 bps PAT 14.3% 11.6% 9.7% 273 bps 454 bps Basic 20.8 16.6 10.3 EPS (Rs) Diluted 19.7 16.0 9.7 *Revenue from operation includes Evosys amounting to Rs 142.4 crore ($19.2m) in Q2FY21 and Rs 133.8 crore ($ 17.6m) in Q1FY21 Mastek Limited | Investor Presentation 2021 | 7 Financial Summary – H1 FY21 Growth Key Performance Metrics H1FY21 H1FY20 YoY Revenue from Operations* ($m) $105.8 $69.9 51.2% (CC) Revenue from Operations* (Rs Crore) 795.8 491.1 62.0% Revenue Other Income (Rs Crore) 20.8 14.3 45.7% Total Income (Rs Crore) 816.6 505.4 61.6% Op. EBITDA 154.7 61.5 151.4% Margins Total EBITDA 175.4 75.8 131.5% (Rs Crore) PBT 147.8 62.7 135.6% PAT 105.7 48.9 116.4% Op. EBITDA 19.4% 12.5% 691 bps Margin (%) Total EBITDA 21.5% 15.0% 649 bps PBT 18.1% 12.4% 569 bps PAT 12.9% 9.7% 328 bps Basic 37.5 20.4 EPS (Rs) Diluted 35.6 19.3 *Revenue from operation includes Evosys amounting to Rs 276.2 crore ($36.8m) in H1FY21 Mastek Limited | Investor Presentation 2021 | 8 Comparison: Quarter-on-Quarter and Year-on-Year (Figures in Rs Crore) Consolidated Financial Highlights Q2 FY21 Operating EBITDA & 12 Months Order Operating Revenue PAT & Margin (%) Margin (%) Backlog* 21.1% 14.3% 17.6% 940.5 86.6 11.6% 386.1 409.7 9.7% 764.5 11.8% 68.1 626.5 59.1 243.6 46.6 28.7 24.6 Q2FY20 Q1FY21 Q2FY21 Q2FY20 Q1FY21 Q2FY21 Q2FY20 Q1FY21 Q2FY21 Q2FY20 Q1FY21 Q2FY21 6.1% QoQ 27.1% QoQ 27.0% QoQ 23.0% QoQ 5.3% QoQ (cc) 202.1% YoY 140.0% YoY 22.4% QoQ (cc) 68.2% YoY 50.1% YoY 56.3% YoY (cc) 42.0% YoY (cc) Mastek Limited | Investor Presentation 2021 | 9 Strengthening the Balance Sheet Balance Sheet Metrics H1 FY’21 - Consolidated Return on Capital Free Cash Flow* Cash & Cash Return on Equity*# Employed*# Equivalent* 23.1% 168.0 20.6% 154.1 476.4 19.8% 414.7 16.0% 17.1% 14.6% 244.5 60.2 FY19 FY20 H1FY21 FY19 FY20 H1FY21 FY19 FY20 H1FY21 FY19 FY20 H1FY21 FCF to PAT: Net Cash: H1FY21: 145.7% H1FY21: Rs 223.4 cr FY20: 147.6% FY20: Rs 81.0 cr FY19: 59.4% FY19: Rs 174.9 cr All figures in Rs Crore * FY20 and H1FY21 includes Evosys numbers Mastek Limited | Investor Presentation 2021 | 10 # Return on Equity = PAT/Average Networth; Return on Capital Employed = EBIT/Average Capital Employed; Quarter numbers are annualized for ROE and ROCE calculations Operational 03 Performance 01 02 04 05 06 Operating Metrics Q2 FY21 Strengthening our business Q2FY21 Q1FY21 Q2FY20 New Clients Added 37 48 11 Active Client (immediately preceding 12 months) 542 504 144 Client Base Top 5 35.1% 34.5% 40.0% Top 10 45.8% 48.1% 57.0% Total Employee 3,354 3,321 1,937 - Offshore 2,283 2,227 1,171 Employee - Onsite 1,071 1,094 766 Base - Diversity (Women employees) 25.8% 25.2% 27.8% LTM attrition 14.7% 18.3% 24.1% DSO Days 71 72 78 Value (In m) – GBP 10.1 10.2 7.2 FX Hedges Average rate/ Rs. 99.3 97.7 96.4 for next 12 Value (In m) – USD 3.6 4.5 1.5 months Average rate/ Rs. 76.0 75.8 72.3 Mastek Limited | Investor Presentation 2021 | 12 Balancing our portfolio Revenue Analysis Q2 FY21 - Consolidated Revenue by Market Region* Revenue by Q2FY20 31.3% 37.1% 8.7% 17.6% 5.3% Industry 1.9% 3.5% 4.3% Segment Government 26.6% Q1FY21 33.6% 17.7% 19.9% 12.8% 16.0% 14.1% 10.8% Retail Services 17.1% 17.7% Health 71.5% Financial Services Q2FY21 35.1% 19.9% 18.2% 12.1%14.7% 65.3% 67.2% Others Revenue by Q2FY20 81.1% 18.9% Contract Type Time & Material Q1FY21 55.3% 44.7% Q2FY20 Q1FY21 Q2FY21 Fixed Price UK & Europe US ME ROW Q2FY21 54.4% 45.6% * ROW includes India, Singapore, Malaysia and Australia Mastek Limited | Investor Presentation 2021 | 13 8.8% 1.0% Operational Performance Revenue By Q2FY20 44.0% 26.1% 16.4% Service Line 3.7% Q2 FY21 – 3.0% 1.1% Consolidated Q1FY21 40.7% 34.7% 11.1% 7.6% Applicant Development Oracle Suite & Cloud Migration 1.8% Digital Commerce 0.2% Application Support & Maintenance 4.2% BI & Analytics Q2FY21 Assurance & Testing 40.8% 34.8% 11.0% 7.3% Agile Consulting 1.7% Mastek Limited | Investor Presentation 2021 | 14 Key wins 04 for the quarter 01 02 03 05 06 Public Sector UK ROW ME • Client: Central • Client: Large government • Client: Government owned Government Department owned investment company in civil aviation company About the deal: Brexit Australia, having presence About the deal: Evosys shall Impact: Innovative new since 30 years, providing be deploying its Cloud solutions to the post alternative assets with a focus Managed Services Program to Brexit Import/Export on infrastructure, real estate deliver an outcome focused trading rules and private capital delivery About the deal: Evosys is jointly implementing the Cloud Transformation Program especially focused on Hybrid Cloud Integration and Enterprise Performance Management Mastek Limited | Investor Presentation 2021 | 16 Healthcare US UK • Client: Multimillion • Client: National Health healthcare giant having Service more than 70 nursing and About the deal: assisted living centers in COVID Impact: Developing a the US across eight states cutting edge collaboration About the deal: Evosys platform for the suite of will be implementing a applications that combine to strategic Oracle cloud ERP create the UK’s COVID Track and HCM implementation and Trace service with a newly created department to address the pandemic Mastek Limited | Investor Presentation 2021 | 17 Manufacturing & Engineering and Construction US UK & Europe Private Sector • Client: A Global manufacturer of industry leading medical products. • Client: A multi billion and About the deal: As a key transformation partner, Mastek is helping the leading global design & customer enhance their online presence by adding ‘Direct to Consumer’ consultancy firm capabilities. In a phase-wise global roll-out, Mastek would leverage About the deal: Multi-million cutting-edge Commerce solutions to enable this customer interact, long term engagement where transact & serve its consumers online Evosys and Mastek shall be transitioning from a Tier 1 • Client: One of the Leading computer gaming peripheral manufacturers in incumbent System Integrator US and providing an outcome About the deal: Evosys shall deploy its GLIDE for Oracle EBS program to focused Cloud Managed completely transform them from OnPremise to Oracle Cloud Applications Services Program • Client: Multi million, 40 years old manufacturing house.